1/39
Looks like no tags are added yet.
Acute Complications of Diabetes
Hyperglycemia
Hypoglycemia
Diabetic Ketoacidosies (DKA)
Hypersmolar Hyperglyciemic Syndrome (HHS)
Hyperglycemia
“Hot and Dry, Sugar HIGH”
Decreased insulin secretion (endogenous)
Decreased insulin sensitivity (non-response)
Increased hepatic production
Decreased peripheral utilixation
Excessive CHO (carb) consumption
—> Possible combination of any
Morning HYPERglycemia: Insulin Waning
Progressive rise in blood glucose from bedtime to morning.
Morning HYPERglycemia: Insulin Waning Treatment
Increasing evening (predinner or bedtime) dose of intermediate- or long-acting insulin
Instituting a dose of insulin before the evening meal if one is not already part of the treatment regimen.
Morning HYPERglycemia: Dawn Phenomenon
(Hint – DOWN insulin)
• Relatively normal blood glucose until early morning hours when levels begin to rise.
Dawn Phenomenon Treatment
Changing the time of injection of evening intermediate-acting insulin from dinnertime to bedtime.
Morning HYPERglycemia: Somogyi Effect
(Hint - SO Much insulin)
• Normal or elevated blood glucose at bedtime, early morning hypoglycemia, and a subsequent increased blood glucose caused by the production of counter-regulatory hormones.
( Extremely low blood sugar in middle of night —> = Somogyi Effect)
Somogyi Effect Treatment
Decreasing evening (predinner or bedtime) dose of intermediate-acting insulin or increasing bedtime snack.
Diabetic Ketoacidosis (DKA)
Caused by a profound deficiency of insulin
Blood Glucose > 250!
Type 1 Diabetes —> most likely to occur in
Acute/Rapid Onset
Diabetic Ketoacidosis (DKA) Characterization
Hyperglycemia
Dehydration
Acidosis
Diabetic Ketoacidosis (DKA) Precipitating Factors
Illness
Infection
Inadequate insulin dosage
Undiagnosed Type 1 Diabetes
Clinical Manifestations of Ketoacidosis:
Dehydration
Poor skin turgor
Dry mucous membranes
tachycardia
Orthostatic hypotension
Lethargy and Weakness early
Skin dry and loose; eyes soft and sunken
Adverse Clinical Manifestations of Ketoacidosis:
Abdominal pain, anorexia, nausea/vomiting
Kussmaul respirations (d/t low pCO2)
Sweet, fruity breath odor
Blood glucose level of ≥ 250 mg/dL
Blood pH lower than 7.30
Serum bicarbonate level < 16 mEq/L
Moderate to high ketone levels in urine or serum
Electrolytes vary according to the degree of dehydration (increased Cr, Hct, BUN)
Diabetic Ketoacidosis (DKA) Less Severe Treatments
• Less severe form may be treated on outpatient basis
Diabetic Ketoacidosis (DKA) Severe Treatments
• Hospitalize for severe fluid and electrolyte imbalance, fever, nausea/vomiting, diarrhea, altered mental state
IV Fluid Administration (0.9 NSS) (too low BG → administer 5%-10% Dextrose)
Continuous Regular Insulin Drip (IV) 0.1U/kg/hr
Monitor BG, renal function, urine output, ECG, electrolytes, VS, and Lung assessment (fluid overload)
Hyperosmolar Hyperglycemic Syndrome (HHS)
A lack of sufficient insulin causes Hypersmolar Hyperglycemia;
glucose levels (>600 mg/dL)
ketosis is minimal or absent
Occurs with T2DM—> insulin resistance
Life-Threatening
Slower Onset (several days)
Hyperosmolar Hyperglycemic Syndrome (HHS) Precipitating Factors
• UTIs, pneumonia, sepsis
• Acute illness
• Newly diagnosed type 2 diabetes
• Impaired thirst sensation and/or inability to replace fluids
Hyperosmolar Hyperglycemic Syndrome (HHS) Systemic Effects
• Enough circulating insulin to prevent ketoacidosis
• Fewer symptoms lead to higher glucose levels (>600 mg/dL)
• More severe neurologic manifestations because of increase serum osmolality
•Ketones absent or minimal in blood and urine
Hyperosmolar Hyperglycemic Syndrome (HHS) Adverse Effects
Seizure
Shocks
Coma
Death
Hyperosmolar Hyperglycemic Syndrome (HHS) Treatment
• Therapy similar to treatment DKA
• Fluid replacement: NaCl infusions
• Insulin as needed
• Monitor serum potassium and replace as needed
•Correct underlying precipitating cause
Hypoglycemia:
“COLD and Clammy, needs some candy”
Low Blood Sugar
< 70mg/dl in Adults
Hypoglycemia: Diabetic Causes
Too much insulin
Too much diabetes medication
Hypoglycemia: Non- Diabetic Causes
Eating less/Exercising More
Medications
Alcohol
Reactive
Hypoglycemia: 15-15 Rule
Test Blood Glucose
Eat/Drink 15grams of Fast Acting Carbs
Wait 15 minutes —> Test Again
15g Simple Carbs:
Fruit juice or regular soda, 4 to 6 oz
3-4 glucose tablets
1 tablespoon of sugar
8 oz milk
1 tablespoon honey
Hypoglycemia Symptoms
S/S of Hypoglycemia
Hunger
Fatigue
Shaking
Sweating
Pale Skin
Headaches
Dizziness
Hypoglycemia Symptoms Severe Symptoms
Severe S/S of Hypoglycemia
Slurred Speech
Blurred Vision
Fainting
Seizures
Coma
Hypoglycemia Treatment:
Glucagon Injection
Inject at 90* angle into THIGH or BUTTOCK
Glucagon stimulates RELEASE of sugar
Angiopathy
Damage to blood vessels secondary to chronic hyperglycemia
• Leading cause of diabetes-related death
• Macrovascular and microvascular
•Tight glucose levels can prevent or minimize complications
Macrovascular Angiopathy
Diseases of large and medium-sized blood vessels
• Greater frequency and earlier onset in patients with diabetes
• Cerebrovascular disease
• Cardiovascular disease
• Peripheral vascular disease
Microvascular Angiopathy
Thickening of vessel membranes in capillaries and arterioles
• Specific to diabetes and includes
• Retinopathy
• Nephropathy
• Dermopathy
Usually appear 10 to 20 years after diagnosis
Diabetic Retinopathy
Microvascular damage to retina
• Most common cause of new cases of adult blindness
Diabetic Retinopathy Treatment
Laser photocoagulation
Most common
Laser destroys ischemic areas of retina
Vitrectomy
Aspiration of blood, membrane, and fibers inside the eye
Drugs to block action of vascular endothelial growth factor (VEGF)
Diabetic Nephropathy
Damage to small blood vessels that supply the glomeruli of the kidney
Leading cause of end-stage renal disease
Risk factors:
Hypertension
Genetics
Smoking
Chronic hyperglycemia
Diabetic Nephropathy Treatment
• Annual screening
• If albuminuria present, drugs to delay progression:
• ACE inhibitors
• Angiotensin II receptor antagonists
• Control of hypertension and blood glucose levels in a healthy range: imperative
Diabetic Neuropathy:
Nerve damage due to metabolic derangements of diabetes
• 60% to 70% of patients with diabetes have some degree of neuropathy
• Reduced nerve conduction and demyelination
• Sensory or autonomic
Diabetic Neuropathy: Distal symmetric polyneuropathy
• Most common form
• Affects hands and/or feet bilaterally
• Loss of sensation, abnormal sensations, pain, and paresthesia
Diabetic Neuropathy Treatment
Managing blood glucose levels
Drug therapy
Topical creams
Tricyclic antidepressants
Selective serotonin and norepinephrine reuptake inhibitors
Antiseizure medications
Diabetic Ulcers: Risk Factors
Previous amputation
Past foot ulcer history
Peripheral neuropathy
Foot deformity
Peripheral vascular disease
Visual impairment
Diabetic nephropathy (especially patients on dialysis)
Poor glycemic control
Cigarette smoking